Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 27 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07635316
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT07165132
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
- Locations
-
- Research Facility Iowa City, Iowa, United States
- Research Facility Lexington, Kentucky, United States
- Research Facility St Louis, Missouri, United States
- Research Facility St Louis, Missouri, United States
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
NCT05636618
- Conditions
- Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Biogenix Molecular Miami, Florida, United States
- The University of Chicago Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
NCT06441331
- Conditions
- CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
- Locations
-
- The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
- University of Texas - MD Anderson Cancer Center Houston, Texas, United States
- Gustave Roussy Cancer Campus Villejuif, France
- Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
NCT06784752
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Hartford Hospital Hartford, Connecticut, United States
NCT05477576
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
- Locations
-
- Research Facility Phoenix, Arizona, United States
- Research Facility Duarte, California, United States
- Research Facility Irvine, California, United States
- Research Facility Los Angeles, California, United States
NCT04090034
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
- Locations
-
- Clinical Research Institute at Methodist Health System Dallas, Texas, United States
- Methodist Dallas Medical Center Dallas, Texas, United States
NCT07150546
- Conditions
- Digestive System Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Unresectable Digestive System Neuroendocrine Neoplasm, +2 more
- Locations
-
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital Atlanta, Georgia, United States
NCT04609592
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- Stanford Cancer Institute Palo Alto Stanford, California, United States
NCT05997056
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +18 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Rocky Mountain Cancer Centers Denver, Colorado, United States
- Texas Oncology Dallas, Texas, United States
- Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +47 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02611024
- Conditions
- Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Massachusetts General Hospital - Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT06253897
- Conditions
- Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +10 more
- Locations
-
- Pearl IRB Indianapolis, Indiana, United States
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
NCT03043664
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
- Lexington Medical Center Columbia, South Carolina, United States
NCT01423734
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Secondary Malignant Neoplasm of Liver
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03220217
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
- Locations
-
- UCLA Medical Center Los Angeles, California, United States
- Medical University of Innsbruck Innsbruck, Austria
- University Clinic for Radiology and Nuclear Medicine Vienna, Austria
- Aarhus University Hospital Aarhus, Denmark
NCT01476592
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT03017690
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Ochsner Medical Center Kenner Kenner, Louisiana, United States
- Mercy Medical Center Baltimore, Maryland, United States
- National Translational Research Group East Setauket, New York, United States
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
NCT05050942
- Conditions
- Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
- Locations
-
- Mayo Clinic Cancer Center (MCCC) - Phoenix Phoenix, Arizona, United States
- UCLA Ahmanson Biological Imaging Center Santa Monica, California, United States
- Rocky Mountain Cancer Centers - Denver - Midtown Denver, Colorado, United States
- Mayo Clinic Hospital - Florida Jacksonville, Florida, United States